Pfizermectin? Is Pfizer Rebranding Ivermectin to Use to treat Covid-19?
As Americans we are expected to blindly trust the government, the FDA, and the CDC in regards to COVID-19 and what does and doesn’t work in treating it.
The problem with that is that they continue lying to us about everything, and they don’t even hide it!
Want the latest example?
Look no further than Pfizer and Merck.
Both companies are now in the process of creating pills to treat Covid in a similar method as Ivermectin.
Was the smear campaign against Ivermectin only done so that the drug could be re-branded to make more money?
Here's more on Merck's claim that they've created a pill to treat Covid from Yahoo News:
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday.
Since molnupiravir does not target the spike protein of the virus - the target of all current COVID-19 vaccines - which defines the differences between the variants, the drug should be equally effective as the virus continues to evolve, said Jay Grobler, head of infectious disease and vaccines at Merck.
Molnupiravir instead targets the viral polymerase, an enzyme needed for the virus to make copies of itself. It is designed to work by introducing errors into the genetic code of the virus.
Data shows that the drug is most effective when given early in the course of infection, Merck said.
The U.S. drugmaker tested its antiviral against nasal swab samples taken from participants in early trials of the drug. Delta was not in wide circulation at the time of those trials, but molnupiravir was tested against lab samples of the variant behind the latest surge in COVID-19 hospitalizations and deaths.
CBS News has more on Pfizer's attempt at making an experimental at-home pill to treat Covid, one that involves a similar protein inhibitor to Ivermectin:
Pfizer said Monday that it is now testing a pill that could help people ward off COVID-19 if a close contact, such as family member, gets the virus.
The drugmaker said it is looking at the efficacy of the pill as used in combination with a low dose of the HIV drug ritonavir in people who are at least 18 years old and live in the same household with someone who has COVID-19.
Pfizer plans to enroll 2,660 people in the late-stage study. Those participating will get either the treatment combination or a fake drug orally twice a day for five to 10 days.
Pfizer in March began an early-stage clinical trial of the new antiviral therapy for the coronavirus, with the goal of rolling it out by year-end. Part of a group of medicines called protease inhibitors, which are used to treat HIV and Hepatitis C, the drug hampers production of enzymes needed for the virus to multiply in human cells.
